• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于肝脏病毒感染的生理性体外人源模型。

Physiomimetic In Vitro Human Models for Viral Infection in the Liver.

机构信息

Department of Biomedical Engineering, University of Miami, Coral Gables, Florida.

Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, Florida.

出版信息

Semin Liver Dis. 2023 Feb;43(1):31-49. doi: 10.1055/a-1981-5944. Epub 2022 Nov 19.

DOI:10.1055/a-1981-5944
PMID:36402129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10005888/
Abstract

Viral hepatitis is a leading cause of liver morbidity and mortality globally. The mechanisms underlying acute infection and clearance, versus the development of chronic infection, are poorly understood. In vitro models of viral hepatitis circumvent the high costs and ethical considerations of animal models, which also translate poorly to studying the human-specific hepatitis viruses. However, significant challenges are associated with modeling long-term infection in vitro. Differentiated hepatocytes are best able to sustain chronic viral hepatitis infection, but standard two-dimensional models are limited because they fail to mimic the architecture and cellular microenvironment of the liver, and cannot maintain a differentiated hepatocyte phenotype over extended periods. Alternatively, physiomimetic models facilitate important interactions between hepatocytes and their microenvironment by incorporating liver-specific environmental factors such as three-dimensional ECM interactions and co-culture with non-parenchymal cells. These physiologically relevant interactions help maintain a functional hepatocyte phenotype that is critical for sustaining viral hepatitis infection. In this review, we provide an overview of distinct, novel, and innovative in vitro liver models and discuss their functionality and relevance in modeling viral hepatitis. These platforms may provide novel insight into mechanisms that regulate viral clearance versus progression to chronic infections that can drive subsequent liver disease.

摘要

病毒性肝炎是全球导致肝脏发病率和死亡率的主要原因。急性感染和清除与慢性感染发展的机制尚未被充分理解。病毒性肝炎的体外模型规避了动物模型的高成本和伦理问题,这些模型也很难转化为研究人类特异性肝炎病毒。然而,体外长期感染建模仍然存在重大挑战。分化的肝细胞最能维持慢性病毒性肝炎感染,但标准的二维模型受到限制,因为它们无法模拟肝脏的结构和细胞微环境,并且无法在较长时间内维持分化的肝细胞表型。相反,生理模型通过纳入肝特异性环境因素,如三维细胞外基质相互作用和与非实质细胞的共培养,促进了肝细胞及其微环境之间的重要相互作用。这些生理相关的相互作用有助于维持功能性肝细胞表型,这对于维持病毒性肝炎感染至关重要。在这篇综述中,我们概述了不同的、新颖的和创新的体外肝脏模型,并讨论了它们在模拟病毒性肝炎方面的功能和相关性。这些平台可能为调节病毒清除与进展为慢性感染的机制提供新的见解,从而导致随后的肝脏疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dce/10005888/44f75af61fc8/10-1055-a-1981-5944-i2200043-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dce/10005888/1c15ab68423d/10-1055-a-1981-5944-i2200043-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dce/10005888/ded9038aa3c1/10-1055-a-1981-5944-i2200043-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dce/10005888/0d8d51be22f7/10-1055-a-1981-5944-i2200043-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dce/10005888/44f75af61fc8/10-1055-a-1981-5944-i2200043-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dce/10005888/1c15ab68423d/10-1055-a-1981-5944-i2200043-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dce/10005888/ded9038aa3c1/10-1055-a-1981-5944-i2200043-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dce/10005888/0d8d51be22f7/10-1055-a-1981-5944-i2200043-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dce/10005888/44f75af61fc8/10-1055-a-1981-5944-i2200043-4.jpg

相似文献

1
Physiomimetic In Vitro Human Models for Viral Infection in the Liver.用于肝脏病毒感染的生理性体外人源模型。
Semin Liver Dis. 2023 Feb;43(1):31-49. doi: 10.1055/a-1981-5944. Epub 2022 Nov 19.
2
Physiologically relevant microsystems to study viral infection in the human liver.用于研究人类肝脏中病毒感染的生理相关微系统。
Front Microbiol. 2022 Sep 28;13:999366. doi: 10.3389/fmicb.2022.999366. eCollection 2022.
3
Bioengineered Liver Cell Models of Hepatotropic Infections.生物工程化肝源细胞模型在嗜肝性感染中的应用。
Viruses. 2021 Apr 27;13(5):773. doi: 10.3390/v13050773.
4
The Viral ORF3 Protein Is Required for Hepatitis E Virus Apical Release and Efficient Growth in Polarized Hepatocytes and Humanized Mice.病毒 ORF3 蛋白是戊型肝炎病毒在上皮细胞顶端释放和高效生长所必需的,并且在人源化小鼠中也是如此。
J Virol. 2021 Nov 9;95(23):e0058521. doi: 10.1128/JVI.00585-21. Epub 2021 Sep 15.
5
Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.丙型肝炎病毒诱导肝细胞中微小RNA miR-146a-5p上调,促进病毒感染并失调与肝病发病机制相关的代谢途径。
J Virol. 2016 Jun 24;90(14):6387-6400. doi: 10.1128/JVI.00619-16. Print 2016 Jul 15.
6
Co-culture of Liver Parenchymal Cells with Non-parenchymal Cells Under 2D and 3D Culture Systems; A Review.二维和三维培养系统中肝实质细胞与非实质细胞的共培养:综述。
Curr Stem Cell Res Ther. 2023;18(7):904-916. doi: 10.2174/1574888X17666220614160957.
7
Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis.乙型肝炎病毒转基因小鼠:病毒免疫生物学和发病机制模型
Curr Top Microbiol Immunol. 1996;206:149-73. doi: 10.1007/978-3-642-85208-4_9.
8
Cooperation of liver cells in health and disease.健康与疾病状态下肝细胞的协作。
Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. doi: 10.1007/978-3-642-56553-3.
9
[Immunopathology of chronic liver diseases].[慢性肝病的免疫病理学]
Verh Dtsch Ges Pathol. 1995;79:186-97.
10
Modeling of HBV and HCV hepatitis with hepatocyte-like cells.利用类肝细胞对乙型肝炎病毒和丙型肝炎病毒肝炎进行建模。
Front Biosci (Schol Ed). 2016 Jan 1;8(1):97-105. doi: 10.2741/s449.

引用本文的文献

1
Human organoids-on-chips for biomedical research and applications.人源类器官芯片用于生物医学研究和应用。
Theranostics. 2024 Jan 1;14(2):788-818. doi: 10.7150/thno.90492. eCollection 2024.
2
Microfluidic strategies for biomimetic lung chip establishment and SARS-CoV2 study.用于仿生肺芯片建立和SARS-CoV-2研究的微流控策略
Mater Today Bio. 2023 Dec 7;24:100905. doi: 10.1016/j.mtbio.2023.100905. eCollection 2024 Feb.

本文引用的文献

1
Transcriptional and Epigenetic Consequences of DMSO Treatment on HepaRG Cells.DMSO 处理对 HepaRG 细胞的转录和表观遗传后果。
Cells. 2022 Jul 26;11(15):2298. doi: 10.3390/cells11152298.
2
A multi-organ chip with matured tissue niches linked by vascular flow.一种具有通过血管流动连接的成熟组织微环境的多器官芯片。
Nat Biomed Eng. 2022 Apr;6(4):351-371. doi: 10.1038/s41551-022-00882-6. Epub 2022 Apr 27.
3
Human liver organoid derived intra-hepatic bile duct cells support SARS-CoV-2 infection and replication.人源肝类器官来源的肝内胆管细胞支持 SARS-CoV-2 感染和复制。
Sci Rep. 2022 Mar 30;12(1):5375. doi: 10.1038/s41598-022-09306-6.
4
Molecular consequences of SARS-CoV-2 liver tropism.SARS-CoV-2 肝脏嗜性的分子后果。
Nat Metab. 2022 Mar;4(3):310-319. doi: 10.1038/s42255-022-00552-6. Epub 2022 Mar 28.
5
Modelling T-cell immunity against hepatitis C virus with liver organoids in a microfluidic coculture system.在微流控共培养系统中使用肝类器官对丙型肝炎病毒的 T 细胞免疫进行建模。
Open Biol. 2022 Mar;12(3):210320. doi: 10.1098/rsob.210320. Epub 2022 Mar 2.
6
Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma.人源肝类器官在 HBV 感染及相关肝细胞癌中的应用:患者来源的原发性模型。
Elife. 2021 Jul 30;10:e60747. doi: 10.7554/eLife.60747.
7
Advances in HBV infection and replication systems in vitro.HBV 感染和复制系统的体外研究进展。
Virol J. 2021 May 29;18(1):105. doi: 10.1186/s12985-021-01580-6.
8
Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的Huh7细胞中的I型干扰素特征
Cell Death Discov. 2021 May 18;7(1):114. doi: 10.1038/s41420-021-00487-z.
9
Liver-Kidney-on-Chip To Study Toxicity of Drug Metabolites.用于研究药物代谢物毒性的肝肾芯片
ACS Biomater Sci Eng. 2018 Jan 8;4(1):78-89. doi: 10.1021/acsbiomaterials.7b00417. Epub 2017 Dec 4.
10
A 3D microfluidic liver model for high throughput compound toxicity screening in the OrganoPlate®.一种用于 OrganoPlate®高通量化合物毒性筛选的 3D 微流控肝脏模型。
Toxicology. 2021 Feb 28;450:152667. doi: 10.1016/j.tox.2020.152667. Epub 2021 Jan 6.